Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan)

AUTHORS

Mohammad Ali Mashhadi 1 , * , Mohhamad Mahdi Koushyar 2 , Mehdi Mohammadi 3

1 Dept. of Hematology and Oncology, Genetic Research Center , Ali Ebne Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran

2 Dept. of Hematology and Oncology, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 . Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

How to Cite: Mashhadi M A, Koushyar M M, Mohammadi M. Outcome of Adult Acute Lymphoblastic Leukemia in South East of Iran (Zahedan), Int J Cancer Manag. 2012 ; 5(3):e80814.

ARTICLE INFORMATION

International Journal of Cancer Management: 5 (3); e80814
Published Online: September 30, 2012
Article Type: Research Article
Received: January 30, 2012
Accepted: April 07, 2012

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Acute lymphoblastic leukemia is a lymphoid malignancy, resulting from autonomous proliferation of monoclonal abnormal stem cell. The aim of this study was to evaluate the response rate and prognostic factor of adult patients suffering from acute lymphoblastic leukemia, who were treated with chemotherapy in south east of Iran and demographic methods were used for this study.

Methods: This study was conducted in Ali Ebne Abitaleb Hospital in south east of Iran (Zahedan) from 2003-2010. All adult patients with acute lymphoblastic leukemia in hematology ward received Vincristin, Daunorubicin, Cyclophosphamide, Prednisolone and high dose Methotrexate for induction therapy. All patients' information was recorded and multivariate analysis and survival studies were performed by using Kaplan-Meier statistics.

Results: Sixty six adult patients entered. Mean age of them was 33 years old (16-68), that 53 (80.3%) cases were male and 13 cases were female. Fifty one (77.3%) cases experienced complete remission and 15 (22.7%) cases had no remission state. In the following year 53% ( 33) was alive with complete remission and 47% ( 31) were dead. Median survival was 13 months. In the end of study 30 cases were in complete remission and alive and 36 (54.5%) were dead.

Conclusion: Our results were comparable with other studies and minimally better than those studies.

Keywords

Acute lymphoblastic leukemia Stem cell Outcome

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

Full text is available in PDF.

COMMENTS

LEAVE A COMMENT HERE: